Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Multicenter Study to Assess the Long -Term Safety of Hydrocodone Bitartrate (HYD) Tablets 20 to 120 mg Once-daily in Subjects With Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain

NCT01400139 is registered in ClinicalTrials.gov with Purdue Pharma LP as lead sponsor.

NCT NCT01400139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01400139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Multicenter Study to Assess the Long -Term Safety of Hydrocodone Bitartrate (HYD) Tablets 20 to 120 mg Once-daily in Subjects With Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain
Lead sponsor
Purdue Pharma LP
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2011
Completion date
October 31, 2013
Enrollment
922 (actual)
Sites
98

Conditions

As the registry lists them; a condition with its own page is linked.

chronic nonmalignant and nonneuropathic pain